AstraZeneca plc 0.6% Potential Decrease Indicated by Jefferies International

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

AstraZeneca plc with EPIC/TICKER (LON:AZN) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘HOLD’ this morning by analysts at Jefferies International. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Jefferies International have set a target price of 7575 GBX on its stock. This would indicate that the analyst believes there is a downside of -.6% from today’s opening price of 7618 GBX. Over the last 30 and 90 trading days the company share price has increased 1397 points and decreased 205 points respectively. The 1 year high for the share price is 7948 GBX while the year low share price is currently 5626 GBX.

AstraZeneca plc has a 50 day moving average of 7,316.50 GBX and the 200 Day Moving Average price is recorded at 7,326.02. There are currently 1,312,225,245 shares in issue with the average daily volume traded being 3,883,448. Market capitalisation for LON:AZN is £100,936,365,845 GBP.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    AstraZeneca's Imfinzi receives FDA approval for limited-stage small cell lung cancer, marking a significant breakthrough in extending patient survival.
    AstraZeneca Plc commits $3.5 billion to boost US research and manufacturing by 2026, creating jobs and expanding its innovation footprint.
    AstraZeneca and Amgen's Tezspire shows promise in reducing nasal polyp size and congestion, offering hope for chronic rhinosinusitis patients.

      Search

      Search